Helius Medical Technologies Inc. (Newton, Pa.) reported it is making progress with its attempts to bring a neuromodulation device to market that can help treat symptoms in multiple sclerosis (MS) patients. On Monday, the company said a pilot study evaluating its investigational portable neuromodulation stimulator (Pons) used to help treat the symptoms of MS, met all of its study objectives. A total of 14 subjects (seven-active and seven-sham control) received treatment with the non-invasive brain stimulation technology and concomitant physiotherapy.